Dr. med. Ingrid Klingmann is specialized in General Medicine, Clinical Pharmacology and Pharmaceutical Medicine.After having joined pharmaceutical industry as medical advisor, she held senior management positions in different international contract research organisations and was responsible for operational, scientific, regulatory and business aspects of international clinical research projects from Phase I to Phase IV.Since January 2003 she has her own pharmaceutical development and site management support consulting company. For 4 years she was also CEO of two investigative sites in London, UK, performing clinical trials in acute and chronic pain as well as musculo-skeletal diseases.Dr. Klingmann is Chairman of the Board of the European Forum for Good Clinical Practice (EFGCP). On behalf of EFGCP she was Work Package Leader of the PatientPartner Project and is currently Coordinator of the IMI project PharmaTrain and she is Work Package Leader of EUPATI, responsible for developing the EUPATI Network, the EUPATI National Platforms and the Ethics Panel. Dr. Klingmann chairs the clinical research module of the post-graduate Master in Regulatory Affairs course at the University of Bonn, Germany, and co-chairs the Diploma Course in Clinical Trial Practices at the University of Basel, Switzerland.